Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Min Li, Hongling Chen, Tong Sun, Zhuo Ma, Xi Chen, Dandan Wu, Wenbin Huang & Xuerong Wang. (2020) p70S6K Promotes Acquired Resistance of Erlotinib Through Induction of Epithelial-Mesenchymal Transition in Non-Small Cell Lung Carcinoma. OncoTargets and Therapy 13, pages 5257-5270.
Read now
Read now
Yang Zhao, Tiantian Li, Shuaiwei Tian, Wei Meng, Yi Sui, Jian Yang, Baocheng Wang, Zhuangzhuang Liang, Heng Zhao, Yipeng Han, Yujie Tang, Lei Zhang & Jie Ma. (2020) Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1. Cancer Management and Research 12, pages 12473-12485.
Read now
Read now
Zhongyuan Gao, Ting Yuan, Xiao Zhou, Ping Ni, Geng Sun, Ping Li, Zhixiang Cheng & Xuerong Wang. (2018) Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression. Cancer Biology & Therapy 19:5, pages 407-415.
Read now
Read now
Tao Xu, Yuanyuan Zong, Lipan Peng, Shuai Kong, Mingliang Zhou, Jianqiang Zou, Jinglei Liu, Ruizheng Miao, Xichao Sun & Leping Li. (2016) Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis. OncoTargets and Therapy 9, pages 815-822.
Read now
Read now
Articles from other publishers (42)
Ting Yuan, Ping Ni, Zuhao Zhang, Dandan Wu, Geng Sun, Haijun Zhang, Baoan Chen, Xuerong Wang & Zhixiang Cheng. (2022) Targeting BET proteins inhibited the growth of non‐small cell lung carcinoma through downregulation of Met expression. Cell Biology International 47:3, pages 622-633.
Crossref
Crossref
Sarah L. Gillen, Joseph A. Waldron & Martin Bushell. (2021) Codon optimality in cancer. Oncogene 40:45, pages 6309-6320.
Crossref
Crossref
Blake A. Jacobson, Zeeshan Ahmad, Sierra Chen, Gabriella Waldusky, Maxwell Dillenburg, Emilia Stoian, Daniel A. Cambron, Anil J. Patel, Manish R. Patel, Carston R. Wagner & Robert A. Kratzke. (2020) 4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer. Investigational New Drugs 39:3, pages 636-643.
Crossref
Crossref
Luis Del Valle, Lu Dai, Hui‐Yi Lin, Zhen Lin, Jungang Chen, Steven R. Post & Zhiqiang Qin. (2021) Role of EIF4G1 network in non‐small cell lung cancers (NSCLC) cell survival and disease progression. Journal of Cellular and Molecular Medicine 25:6, pages 2795-2805.
Crossref
Crossref
Hongxia Tan, Li He & Zhenshun Cheng. (2020) Inhibition of eIF4E signaling by ribavirin selectively targets lung cancer and angiogenesis. Biochemical and Biophysical Research Communications 529:3, pages 519-525.
Crossref
Crossref
Olga Kelemen, Indira Pla, Aniel Sanchez, Melinda Rezeli, Attila Marcell Szasz, Johan Malm, Viktoria Laszlo, Ho Jeong Kwon, Balazs Dome & Gyorgy Marko‐Varga. (2020) Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas. Clinical and Translational Medicine 10:2.
Crossref
Crossref
Oshrat Attar-Schneider, Mahmoud Dabbah, Liat Drucker & Maya Gottfried. (2020) Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic. Cellular Signalling 65, pages 109456.
Crossref
Crossref
Aseel J. Marzoq, Shakhawan A. Mustafa, Luzia Heidrich, Jörg D. Hoheisel & Mohamed Saiel Saeed Alhamdani. (2019) Impact of the secretome of activated pancreatic stellate cells on growth and differentiation of pancreatic tumour cells. Scientific Reports 9:1.
Crossref
Crossref
Takuya Shintani, Kazuma Higashisaka, Makiko Maeda, Masaya Hamada, Ryosuke Tsuji, Koudai Kurihara, Yuri Kashiwagi, Atsuhiro Sato, Masanori Obana, Ayaha Yamamoto, Keisuke Kawasaki, Ying Lin, Takashi Kijima, Yuhei Kinehara, Yoshihiro Miwa, Shinichiro Maeda, Eiichi Morii, Atsushi Kumanogoh, Yasuo Tsutsumi, Izumi Nagatomo & Yasushi Fujio. (2018) Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer. Oncotarget 9:101, pages 37520-37533.
Crossref
Crossref
Mengwu Pan, Lingling Hou, Jingsi Zhang, Diandian Zhao, Jilei Hua, Ziling Wang, Jinsheng He, Hong Jiang, Honggang Hu & Lishu Zhang. (2017) Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells. Molecular and Cellular Biochemistry 441:1-2, pages 63-76.
Crossref
Crossref
Janet L. Oblinger, Sarah S. Burns, Jie Huang, Li Pan, Yulin Ren, Rulong Shen, A. Douglas Kinghorn, D. Bradley Welling & Long-Sheng Chang. (2018) Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Experimental Neurology 299, pages 299-307.
Crossref
Crossref
Androulla Elia, Ricky Henry-Grant, Charlotte Adiseshiah, Catherine Marboeuf, Rebecca J Buckley, Michael J Clemens, Satvinder Mudan & Stéphane Pyronnet. (2017) Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL. Cell Death & Disease 8:12.
Crossref
Crossref
Baolai Zhang, Su Zhang, Lijuan Zhu, Xue Chen, Yunfeng Zhao, Li Chao, Juanping Zhou, Xing Wang, Xinyang Zhang & Nengqian Ma. (2017) Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5. Toxicology and Applied Pharmacology 336, pages 1-7.
Crossref
Crossref
Puyu Shi, You-Take Oh, Liang Deng, Guojing Zhang, Guoqing Qian, Shuo Zhang, Hui Ren, Grant Wu, Benjamin LegendreJrJr, Emily Anderson, Suresh S. Ramalingam, Taofeek K. Owonikoko, Mingwei Chen & Shi-Yong Sun. (2017) Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation. Clinical Cancer Research 23:21, pages 6567-6579.
Crossref
Crossref
Shu-Yan Han, Wei Zhao, Hai-Bo Han, Hong Sun, Dong Xue, Yan-Na Jiao, Xi-Ran He, Shan-Tong Jiang & Ping-Ping Li. (2017)
Marsdenia tenacissima
extract overcomes Axl- and Met-mediated erlotinib and gefitinib cross-resistance in non-small cell lung cancer cells
. Oncotarget 8:34, pages 56893-56905.
Crossref
Crossref
Lu Dai, Zhen Lin, Yueyu Cao, Yihan Chen, Zengguang Xu & Zhiqiang Qin. (2017) Targeting EIF4F complex in non-small cell lung cancer cells. Oncotarget 8:33, pages 55731-55735.
Crossref
Crossref
Ling Hao, Boyu Du & Xueyan Xi. (2017) TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis. Oncology Letters 14:2, pages 2153-2164.
Crossref
Crossref
Zhiyan Lu, Youzhang Xiao, Xing Liu, Zaipeng Zhang, Feng Xiao & Yongyi Bi. (2017) Matrine reduces the proliferation of A549 cells via the p53/p21/PCNA/eIF4E signaling pathway. Molecular Medicine Reports 15:5, pages 2415-2422.
Crossref
Crossref
Yi-Ting Chen, Hung-Pei Tsai, Chun-Chieh Wu, Jaw-Yuan Wang & Chee-Yin Chai. (2017) Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma. Pathology - Research and Practice 213:5, pages 490-495.
Crossref
Crossref
Nabil F. Saba, Yuxiang Wang, Hongpeng Fu, Lydia Koenig, Fadlo R. Khuri, Dong M. Shin & Zhuo (Georgia) Chen. (2017) Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non–Small-Cell Lung Cancer. Clinical Lung Cancer 18:3, pages e203-e210.
Crossref
Crossref
Gang Li, Tie Chong, Xiaolong Xiang, Jie Yang & Hongliang Li. (2017) Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E. Oncology Reports 38:4, pages 1995-2002.
Crossref
Crossref
Puyu Shi, You-Take Oh, Guojing Zhang, Weilong Yao, Ping Yue, Yikun Li, Rajani Kanteti, Jacob Riehm, Ravi Salgia, Taofeek K. Owonikoko, Suresh S. Ramalingam, Mingwei Chen & Shi-Yong Sun. (2016) Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Cancer Letters 380:2, pages 494-504.
Crossref
Crossref
Oshrat Attar-Schneider, Liat Drucker & Maya Gottfried. (2016) Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI. Laboratory Investigation 96:9, pages 1004-1015.
Crossref
Crossref
Jack Zhang & Andy Babic. (2016)
Regulation of the
MET
oncogene: molecular mechanisms
. Carcinogenesis 37:4, pages 345-355.
Crossref
Crossref
Ji Li, Yijiang Huang, Yunsuo Gao, Haihong Wu, Wen Dong & Lina Liu. (2016) Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis. Biochemical and Biophysical Research Communications 472:2, pages 299-305.
Crossref
Crossref
Oshrat Attar-Schneider, Victoria Zismanov, Liat Drucker & Maya Gottfried. (2015) Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation. Tumor Biology 37:4, pages 4755-4765.
Crossref
Crossref
JING WAN, FANG SHI, ZHANZHAN XU & MIN ZHAO. (2015) Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells. International Journal of Oncology 47:6, pages 2217-2225.
Crossref
Crossref
You-Take Oh, Ping Yue, Dongsheng Wang, Jing-Shan Tong, Zhuo G. Chen, Fadlo R. Khuri & Shi-Yong Sun. (2015) Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling. Oncotarget 6:38, pages 41324-41338.
Crossref
Crossref
Fang Liu, Xuefeng Wang, Jiebing Li, Kuo Gu, Liyan Lv, Shuai Zhang, Dehai Che, Jingyan Cao, Shi Jin & Yan Yu. (2015) miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer. Cell Proliferation 48:5, pages 582-592.
Crossref
Crossref
Yazhou Cui, Shuyang Xie, Jing Luan, Xiaoyan Zhou & Jinxiang Han. (2015) Identification of the receptor tyrosine kinases (RTKs)‐oriented functional targets of miR‐206 by an antibody‐based protein array. FEBS Letters 589:16, pages 2131-2135.
Crossref
Crossref
Saori Fujita-Sato, Jacqueline Galeas, Morgan Truitt, Cameron Pitt, Anatoly Urisman, Sourav Bandyopadhyay, Davide Ruggero & Frank McCormick. (2015) Enhanced MET Translation and Signaling Sustains K-Ras–Driven Proliferation under Anchorage-Independent Growth Conditions. Cancer Research 75:14, pages 2851-2862.
Crossref
Crossref
Shahram Khosravi, Kevin J. Tam, Gholamreza S. Ardekani, Magdalena Martinka, Kevin J. McElwee & Christopher J. Ong. (2015) eIF4E Is an Adverse Prognostic Marker of Melanoma Patient Survival by Increasing Melanoma Cell Invasion. Journal of Investigative Dermatology 135:5, pages 1358-1367.
Crossref
Crossref
Christos Demosthenous, Jing Jing Han, Mary J. Stenson, Matthew J. Maurer, Linda E. Wellik, Brian Link, Kristen Hege, Ahmet Dogan, Eduardo Sotomayor, Thomas Witzig & Mamta Gupta. (2015) Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma. Oncotarget 6:11, pages 9488-9501.
Crossref
Crossref
Vidya P. Ramamurthy, Senthilmurugan Ramalingam, Lalji Gediya, Andrew K. Kwegyir-Afful & Vincent C.O. Njar. (2014) Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines. Oncotarget 6:5, pages 3195-3210.
Crossref
Crossref
Wenshuai Pang, Xin Tian, Fan Bai, Ruiyu Han, Juan Wang, Haitao Shen, Xianghong Zhang, Yueping Liu, Xia Yan, Feng Jiang & Lingxiao Xing. (2014) Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer. Molecular Cancer 13:1.
Crossref
Crossref
Klaus-Peter Knoch, Suchita Nath-Sain, Antje Petzold, Hendryk Schneider, Mike Beck, Carolin Wegbrod, Anke Sönmez, Carla Münster, Anne Friedrich, Merja Roivainen & Michele Solimena. (2014) PTBP1 is required for glucose-stimulated cap-independent translation of insulin granule proteins and Coxsackieviruses in beta cells. Molecular Metabolism 3:5, pages 518-530.
Crossref
Crossref
Weidong Li, Xuejun Jin, Xubin Deng, Gong Zhang, Bingqian Zhang & Lei Ma. (2014) The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochemical and Biophysical Research Communications 449:2, pages 235-240.
Crossref
Crossref
Nathaniel Robichaud & Nahum Sonenberg. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine
73
113
.
Armen Parsyan & Karen L. Reckamp. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine
557
574
.
Rui Li, Zhongliang Hu, Shi-Yong Sun, Zhuo G. Chen, Taofeek K. Owonikoko, Gabriel L. Sica, Suresh S. Ramalingam, Walter J. Curran, Fadlo R. Khuri & Xingming Deng. (2013) Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics 12:10, pages 2200-2212.
Crossref
Crossref
Manish R. Patel, Joe Jay-Dixon, Ahad A. Sadiq, Blake A. Jacobson & Robert A. Kratzke. (2013) Resistance to EGFR-TKI Can Be Mediated through Multiple Signaling Pathways Converging upon Cap-Dependent Translation in EGFR-Wild Type NSCLC. Journal of Thoracic Oncology 8:9, pages 1142-1147.
Crossref
Crossref
Mengyan Wu, Yingxia Liu, Xiaoqing Di, Haixian Kang, Hua Zeng, Yi Zhao, Kangrong Cai, Tianyun Pang, Sen Wang, Yunhong Yao & Xinrong Hu. (2013) EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma. Medical Oncology 30:1.
Crossref
Crossref